课题基金 / 基金详情

Production mechanisms and roles of antibodies to glutamate receptor in ac ute encephalitis.

Production mechanisms and roles of antibodies to glutamate receptor in ac ute encephalitis.
急性脑炎中谷氨酸受体抗体的产生机制和作用。
批准号:
21591342
负责人:
TAKAHASHI Yukitoshi
金额:
$3.0万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

TAKAHASHI Yukitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
在非疱疹性急性边缘脑炎(NHALE)患者脑脊液中,GluRψ2(NR2B)和GluRζ1(NR1)抗体与临床进化有关。NMDAR抗体似乎内化了突触外的NMDAR,因为这些抗体可以阻止培养的大鼠神经元的凋亡。这些抗体似乎不整合突触NMDAR,因为它们不影响CREB(cAMP-Responsive-Element-Binding protein)的磷酸化。这些可能有助于NHALE相对较好的结果。
英文摘要
In CSF from patients with non-herpetic acute limbic encephalitis(NHALE), antibodies to GluRψ2(NR2B) and GluRζ1(NR1) we re related with clinical evolution. Antibodies to NMDAR seemed to internalize extra-synaptic NMDAR, because those antibod i es prevent ed apoptosis of rat cultured neurons. Those antibodies seemed not to inte rnalize synaptic NMDAR, because those did not affect phosphorylation of CREB(cAMP-Responsive-Element-Binding protein). These may contribute to the relatively better outcome of NHALE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1600-0404.2009.01198.x
发表时间: 2010-04-01
期刊: ACTA NEUROLOGICA SCANDINAVICA
影响因子: 3.5
作者: [Sakuma, H., Awaya, Y., Sasaki, M.]
通讯作者: Sasaki, M.
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [下島圭子, 他8名]
通讯作者: 他8名
特許出願
专利申请
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: []
通讯作者:
Autoantibodies to NMDA-type GluRε2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua
拉斯穆森脑炎和慢性进行性部分性癫痫患者的 NMDA 型 GluRε2 自身抗体
DOI: --
发表时间:
期刊: Epilepsia
影响因子: 5.6
作者: [Miyazaki M., Nemoto H., Takahashi Y, et. al., Yukitoshi Takahashi]
通讯作者: Yukitoshi Takahashi
共 167 条
    Roles of autoantibodies to glutamate receptors and cellular immunity in acute encephalitis
    Autoimmunity against GluR involving mechanisms of onset and sequelae in patients with acute encephalitis.
    Role of autoantibodies against Glutamate receptors and development of immunological treatment in patients with acute encephalitis and encephalopathies
    海外基金